On 10 September 2026, COST Actions CardioPharmaGENET (CA24165) and INFLAMomx (CA24166) successfully organised the joint webinar “Precision Medicine at the Crossroads of Cardiovascular Disease and Inflammation.” The online event brought together 85 participants for an interdisciplinary discussion on the connections between cardiovascular disease, chronic inflammation, and precision medicine. Moderated by Dr. Yvan Devaux, the webinar…
